Correction to: Cell Death Disease (2016) 7, e2388; https://doi.org/10.1038/cddis.2016.260; published online 29 September 2016
Following publication of their article, the authors noticed that there were minor errors in Figs. 3 and  7. The errors had no effect on the scientific content or conclusions. The rectified figures are given below.
â–“
â–“
The authors apologise for any inconvenience this may have caused.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Wei, S., Zhang, Zy., Fu, Sl. et al. Correction to: Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma. Cell Death Dis 9, 829 (2018). https://doi.org/10.1038/s41419-018-0880-7
Published:
DOI: https://doi.org/10.1038/s41419-018-0880-7
